Can “Digital Therapeutics” Be as Good as Drugs?

The Pharma Dispatch is a hand-curated newsletter compiled weekly to go beyond the headlines and bring you the most interesting developments related to the pharmaceutical, biotech and medical research from around the world.

If you enjoy what you read here, please consider forwarding and sharing it to spread the word.

Entrepreneurs are betting on apps that improve—or just replace—prescription medication.

A new crop of high-tech companies have designed programs aimed at helping people prevent or even reverse their diabetes.

Businesses that are serious about reducing health care costs should take a serious look at digital therapeutics, which have the potential to provide effective, low-cost ways to prevent and treat chronic diseases and their consequences.

It’s hard to characterize what the future of healthcare IT will look like without evoking some form of the word “uncertainty.” With regulatory changes ahead and a fuzzy idea of the economy will look, barriers to innovation are expected.

Powered by Luminary Labs, the Alexa Diabetes Challenge aims to spur the creation of mobile apps using Amazon’s Alexa voice-enabled technology for patients recently diagnosed with Type 2 diabetes

Health companies have been chasing the problem of non-invasive blood sugar monitoring for decades. Apple and Alphabet's Verily follow decades of work by health sciences companies.

If there was ever an industry ripe for disruption, it is healthcare.

If you made it this far, thanks for reading. I’d love to hear which specific topics or sections you would like to know more about and in general, if you have any suggestions, please do write to me at: [email protected]